Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 12

1.

Quantification by LC-MS(E) of outer membrane vesicle proteins of the Bexsero® vaccine.

Tani C, Stella M, Donnarumma D, Biagini M, Parente P, Vadi A, Magagnoli C, Costantino P, Rigat F, Norais N.

Vaccine. 2014 Mar 5;32(11):1273-9. doi: 10.1016/j.vaccine.2014.01.011. Epub 2014 Jan 23.

PMID:
24462403
2.

Structural characterisation, stability and antibody recognition of chimeric NHBA-GNA1030: an investigational vaccine component against Neisseria meningitidis.

Martino A, Magagnoli C, De Conciliis G, D'Ascenzi S, Forster MJ, Allen L, Brookes C, Taylor S, Bai X, Findlow J, Feavers IM, Rodger A, Bolgiano B.

Vaccine. 2012 Feb 8;30(7):1330-42. doi: 10.1016/j.vaccine.2011.12.066. Epub 2011 Dec 27.

PMID:
22210226
3.

Structural organization of NadADelta(351-405), a recombinant MenB vaccine component, by its physico-chemical characterization at drug substance level.

Magagnoli C, Bardotti A, De Conciliis G, Galasso R, Tomei M, Campa C, Pennatini C, Cerchioni M, Fabbri B, Giannini S, Mattioli GL, Biolchi A, D'Ascenzi S, Helling F.

Vaccine. 2009 Mar 26;27(15):2156-70. doi: 10.1016/j.vaccine.2009.01.099. Epub 2009 Jan 31.

PMID:
19356620
4.

Physicochemical characterisation of glycoconjugate vaccines for prevention of meningococcal diseases.

Bardotti A, Averani G, Berti F, Berti S, Carinci V, D'Ascenzi S, Fabbri B, Giannini S, Giannozzi A, Magagnoli C, Proietti D, Norelli F, Rappuoli R, Ricci S, Costantino P.

Vaccine. 2008 Apr 24;26(18):2284-96. doi: 10.1016/j.vaccine.2008.01.022. Epub 2008 Feb 15.

PMID:
18378363
5.

Physicochemical characterisation of the pertussis vaccine.

Ceccarini C, Contorni M, Costantino P, D'Ascenzi S, Gallo E, Maffei M, Mannucci D, Marsili I, Magagnoli C, Peppoloni S, Rappuoli R, Ravenscroft N, Ricci S.

Dev Biol (Basel). 2000;103:175-88.

PMID:
11214235
6.

Detoxification of the Helicobacter pylori cytotoxin.

Manetti R, Massari P, Marchetti M, Magagnoli C, Nuti S, Lupetti P, Ghiara P, Rappuoli R, Telford JL.

Infect Immun. 1997 Nov;65(11):4615-9.

7.

Mutations in the A subunit affect yield, stability, and protease sensitivity of nontoxic derivatives of heat-labile enterotoxin.

Magagnoli C, Manetti R, Fontana MR, Giannelli V, Giuliani MM, Rappuoli R, Pizza M.

Infect Immun. 1996 Dec;64(12):5434-8.

8.

Construction of nontoxic derivatives of cholera toxin and characterization of the immunological response against the A subunit.

Fontana MR, Manetti R, Giannelli V, Magagnoli C, Marchini A, Olivieri R, Domenighini M, Rappuoli R, Pizza M.

Infect Immun. 1995 Jun;63(6):2356-60.

9.

A genetically detoxified derivative of heat-labile Escherichia coli enterotoxin induces neutralizing antibodies against the A subunit.

Pizza M, Fontana MR, Giuliani MM, Domenighini M, Magagnoli C, Giannelli V, Nucci D, Hol W, Manetti R, Rappuoli R.

J Exp Med. 1994 Dec 1;180(6):2147-53.

10.

Probing the structure-activity relationship of Escherichia coli LT-A by site-directed mutagenesis.

Pizza M, Domenighini M, Hol W, Giannelli V, Fontana MR, Giuliani MM, Magagnoli C, Peppoloni S, Manetti R, Rappuoli R.

Mol Microbiol. 1994 Oct;14(1):51-60.

PMID:
7830560
11.

Common features of the NAD-binding and catalytic site of ADP-ribosylating toxins.

Domenighini M, Magagnoli C, Pizza M, Rappuoli R.

Mol Microbiol. 1994 Oct;14(1):41-50.

PMID:
7830559
12.

NAD synthesis in human erythrocytes: study of adenylyl transferase activities in patients bearing purine enzyme disorders.

Sestini S, Pescaglini M, Magagnoli C, Jacomelli G, Rocchigiani M, Simmonds HA.

Adv Exp Med Biol. 1991;309B:319-22. No abstract available.

PMID:
1664184

Supplemental Content

Loading ...
Support Center